KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2025)

Ginkgo Bioworks Holdings' Assets Average history spans 5 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Assets Average fell 19.22% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, down 19.22%, while the annual FY2025 figure was $1.2 billion, 17.93% down from the prior year.
  • Assets Average reached $1.2 billion in Q4 2025 per DNA's latest filing, down from $1.2 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $2.5 billion in Q1 2023 to a low of $1.2 billion in Q4 2025.
  • Average Assets Average over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2021.
  • Peak YoY movement for Assets Average: soared 71.8% in 2022, then tumbled 34.49% in 2024.
  • A 5-year view of Assets Average shows it stood at $2.1 billion in 2021, then increased by 4.46% to $2.2 billion in 2022, then fell by 16.29% to $1.8 billion in 2023, then dropped by 22.57% to $1.4 billion in 2024, then decreased by 19.22% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for DNA's Assets Average are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.3 billion (Q2 2025).